Clover Health Investments (CLOV) just unveiled an announcement.
Clover Health Investments, Corp. has expanded its Board of Directors, appointing Thomas L. Tran as a Class II director and member of the Audit Committee. Bringing over 35 years of financial expertise in healthcare, Tran’s extensive background includes a recent role as CFO of Upstream Care and previous CFO position at Molina Healthcare. His director compensation includes a pro-rata annual retainer and a prorated restricted stock unit award. Tran has also signed the standard indemnification agreement with the company, ensuring protection against liabilities related to his directorship. No conflicts of interest were reported in his appointment.
See more insights into CLOV stock on TipRanks’ Stock Analysis page.
